These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 20860816)

  • 1. Fibronectin 1 mRNA expression correlates with advanced disease in renal cancer.
    Waalkes S; Atschekzei F; Kramer MW; Hennenlotter J; Vetter G; Becker JU; Stenzl A; Merseburger AS; Schrader AJ; Kuczyk MA; Serth J
    BMC Cancer; 2010 Sep; 10():503. PubMed ID: 20860816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caveolin 1 mRNA is overexpressed in malignant renal tissue and might serve as a novel diagnostic marker for renal cancer.
    Waalkes S; Eggers H; Blasig H; Atschekzei F; Kramer MW; Hennenlotter J; Tränkenschuh W; Stenzl A; Serth J; Schrader AJ; Kuczyk MA; Merseburger AS
    Biomark Med; 2011 Apr; 5(2):219-25. PubMed ID: 21473727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered messenger RNA and protein expressions for insulin-like growth factor family members in clear cell and papillary renal cell carcinomas.
    Cheung C; Vesey D; Cotterill A; Douglas M; Gobe G; Nicol D; Johnson D
    Int J Urol; 2005 Jan; 12(1):17-28. PubMed ID: 15661050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Messenger RNA expression ratios among four genes predict subtypes of renal cell carcinoma and distinguish oncocytoma from carcinoma.
    Chen YT; Tu JJ; Kao J; Zhou XK; Mazumdar M
    Clin Cancer Res; 2005 Sep; 11(18):6558-66. PubMed ID: 16166433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas.
    Huo L; Sugimura J; Tretiakova MS; Patton KT; Gupta R; Popov B; Laskin WB; Yeldandi A; Teh BT; Yang XJ
    Hum Pathol; 2005 Mar; 36(3):262-8. PubMed ID: 15791570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased selenium-binding protein 1 mRNA expression is associated with poor prognosis in renal cell carcinoma.
    Ha YS; Lee GT; Kim YH; Kwon SY; Choi SH; Kim TH; Kwon TG; Yun SJ; Kim IY; Kim WJ
    World J Surg Oncol; 2014 Sep; 12():288. PubMed ID: 25227434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of kidney cancer: association of hyaluronic acid family with histological subtypes and metastasis.
    Chi A; Shirodkar SP; Escudero DO; Ekwenna OO; Yates TJ; Ayyathurai R; Garcia-Roig M; Gahan JC; Manoharan M; Bird VG; Lokeshwar VB
    Cancer; 2012 May; 118(9):2394-402. PubMed ID: 21887686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analysis of clinical significance of stem-cell related factors in renal cell cancer.
    Liu Y; Zhang C; Fan J; Xiao L; Yin B; Zhou L; Xia S
    World J Surg Oncol; 2011 Oct; 9():121. PubMed ID: 21982273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-inducible factor-2alpha mRNA expression in human renal cell carcinoma.
    Sandlund J; Ljungberg B; Wikström P; Grankvist K; Lindh G; Rasmuson T
    Acta Oncol; 2009; 48(6):909-14. PubMed ID: 19322701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT.
    Young JR; Margolis D; Sauk S; Pantuck AJ; Sayre J; Raman SS
    Radiology; 2013 May; 267(2):444-53. PubMed ID: 23382290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiling separates chromophobe renal cell carcinoma from oncocytoma and identifies vesicular transport and cell junction proteins as differentially expressed genes.
    Rohan S; Tu JJ; Kao J; Mukherjee P; Campagne F; Zhou XK; Hyjek E; Alonso MA; Chen YT
    Clin Cancer Res; 2006 Dec; 12(23):6937-45. PubMed ID: 17145811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of cyclooxygenase-1 correlates with poor prognosis in renal cell carcinoma.
    Yu ZH; Zhang Q; Wang YD; Chen J; Jiang ZM; Shi M; Guo X; Qin J; Cui GH; Cai ZM; Gui YT; Lai YQ
    Asian Pac J Cancer Prev; 2013; 14(6):3729-34. PubMed ID: 23886173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism and function of decreased FOXO1 in renal cell carcinoma.
    Zhou L; Yin B; Liu Y; Hong Y; Zhang C; Fan J
    J Surg Oncol; 2012 Jun; 105(8):841-7. PubMed ID: 22213032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tr-KIT/c-KIT ratio in renal cell carcinoma.
    Ergün S; Altay DU; Güneş S; Büyükalpelli R; Karahan SC; Tomak L; Abur Ü
    Mol Biol Rep; 2019 Oct; 46(5):5287-5294. PubMed ID: 31342295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and prognostic significance of a comprehensive epithelial-mesenchymal transition gene set in renal cell carcinoma.
    Chen D; Gassenmaier M; Maruschke M; Riesenberg R; Pohla H; Stief CG; Zimmermann W; Buchner A
    J Urol; 2014 Feb; 191(2):479-86. PubMed ID: 24012533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the expression of CARMA3 as a prognostic tumor marker in renal cell carcinoma.
    Wu GL; Yuan JL; Huang XD; Rong JF; Zhang LX; Liu YP; Wang FL
    Tumour Biol; 2013 Dec; 34(6):3431-5. PubMed ID: 23771851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of G250 mRNA expression in renal epithelial neoplasms by real-time reverse transcription-PCR of dissected tissue from paraffin sections.
    Bismar TA; Bianco FJ; Zhang H; Li X; Sarkar FH; Sakr WA; Grignon DJ; Che M
    Pathology; 2003 Dec; 35(6):513-7. PubMed ID: 14660102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of C3 and FN1 as potential biomarkers associated with progression and prognosis for clear cell renal cell carcinoma.
    Dong Y; Ma WM; Yang W; Hao L; Zhang SQ; Fang K; Hu CH; Zhang QJ; Shi ZD; Zhang WD; Fan T; Xia T; Han CH
    BMC Cancer; 2021 Oct; 21(1):1135. PubMed ID: 34688260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular cell adhesion molecule 1 predicts cancer-free survival in clear cell renal carcinoma patients.
    Shioi K; Komiya A; Hattori K; Huang Y; Sano F; Murakami T; Nakaigawa N; Kishida T; Kubota Y; Nagashima Y; Yao M
    Clin Cancer Res; 2006 Dec; 12(24):7339-46. PubMed ID: 17189405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of a multicolour fluorescence in situ hybridisation-based assay for subtyping of renal cell tumours.
    Sanjmyatav J; Hauke S; Gajda M; Hartmann A; Moch H; Meyer B; Pryalukhin A; Grimm MO; Junker K
    Eur Urol; 2013 Oct; 64(4):689-91. PubMed ID: 23790440
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.